The Pharmacy and Poisons Board (PPB) has ordered the recall of a drug named Efinox 1% w/v Batch No. 82979 and Efinox 0.5% w/v Batch No. 82978 manufactured by Laboratory and Allied Ltd, Kenya.
The recall iorder was made due to labeling mix-ups where the correct product was identified, but the wrong strength was applied.
An investigation by Laboratory and Allied Ltd revealed that there was likely a mix-up between 0.5% w/v and 1% w/v strengths of the Efinox Nasal Drops during the labeling and packing process of the above batches.
“In light of this, the Board advises all pharmaceutical outlets, healthcare facilities, healthcare professionals, and members of the public to immediately STOP the further distribution, sale, issuance, or use of the affected product batches,” read the statement in part.
“The products should be returned to the nearest healthcare facility or respective suppliers.”
PPB Recalls Efinox Drugs
The Board encouraged the public to report any suspected cases of sub-standard medicines or adverse drug reactions to the nearest healthcare facility or the Pharmacy and Poisons Board.
However, this is not the first time the Board recalled drugs over issues of labelling.
Earlier in September, the PPB issued a recall for Flamodip tablets, manufactured by Medico Remedies, citing a labeling error.
Also Read: Laos: What You Need to Know About Poisoning That Has Killed 6 Tourists
Earlier Recalls Over Labeling Errors
In a statement, the Board highlighted that the product’s labeling inaccurately reflects its content.
“The secondary packaging is labeled as Flamodip-5 (Amlodipine), while the primary packaging is labeled as Flamodip-5 (Enalapril),” the statement read.
The PPB warned the public against the use, sale, and distribution of the affected product.
Flamodip-5 (Amlodipine) is commonly prescribed to treat high blood pressure in adults and children aged six years and older.
Also Read: Govt Recalls Toxic Popular Unga from Market; Warns Against Consumption
It is also used to manage certain types of anginas (chest pain) and coronary artery disease, which involves the narrowing of blood vessels supplying blood to the heart.
On the other hand, Enalapril is used to treat high blood pressure and heart failure (the weakening of heart function).
Amlodipine works by relaxing blood vessels, allowing blood to flow more easily, thereby reducing blood pressure while Enalapril relaxes and widens blood vessels, helping the heart pump blood more effectively, which in turn lowers elevated blood pressure.
Follow our WhatsApp Channel and join our WhatsApp Group for real-time news updates.
